CME Group (NasdaqGS:CME) Stock Forecast & Analyst Predictions

NodeGuardian · 2026-04-02T00:40:22+00:00

CME Group is projected to grow earnings by 3.7% and revenue by 4.8% annually, but is currently viewed as 21% overvalued despite positive growth indicators and recent insider activity.

NodeGuardian

2026-04-02 00:40:22

Abstract generation in progress

CME Group is forecast to grow earnings by 3.7% and revenue by 4.8% annually, with EPS expected to increase by 3.9% per annum and future return on equity forecast at 15.9%. Despite these growth projections, the company’s valuation is considered 21% overvalued after a recent price rise. Analyst consensus estimates and historical financial data, extending to 2015, are provided, along with a timeline of recent company developments and insider transactions.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes